Pulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research
May 10, 2024 05:00 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- The use of novel therapies and treatment strategies has encouraged significant developments for PAH. The global market for pulmonary...
[Latest] Global Pulmonary Arterial Hypertension (PAH) Market Size/Share Worth USD 326.9 Million by 2030 at an 5.20% CAGR: Markets N Research (Size, Report, Access, Growth, Trends, Dynamics, Value)
March 13, 2023 12:00 ET
|
Markets N Research
Chicago, March 13, 2023 (GLOBE NEWSWIRE) -- Markets N Research has recently released expansive research on Global Pulmonary Arterial Hypertension (PAH) Market with 220+ market data Tables, Pie...
Pulmonary Arterial Hypertension Market Worth ($10.88 Billion by 2028) Lead by Asia Pacific Region (6.5% CAGR) – Global Report by The Insight Partners
February 28, 2023 09:03 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and...
Insights on the Pulmonary Arterial Hypertension Global Market to 2027 - Advanced Oral Drugs for Pulmonary Arterial Hypertension Presents Opportunities
January 26, 2022 06:13 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2021-2027) by Drug Class, Route of Administration, Distribution Mode, and Geography, IGR Competitive Analysis,...
Worldwide Pulmonary Arterial Hypertension Industry to 2026 - Advance Oral Drugs for Pulmonary Arterial Hypertension Present Opportunities
July 05, 2021 04:28 ET
|
Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis...
Worldwide Pulmonary Arterial Hypertension Industry to 2025 - Featuring Gilead Sciences, United Therapeutics and Novartis International Among Others
January 20, 2021 06:33 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2020-2025) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis and the...